Veterinary & Pet Therapeutics

Pet owners are increasingly turning to cannabinoid-based products for their companion animals, and Veterinary & Pet Therapeutics covers the science, products, and regulations shaping this emerging market. We report on clinical research into CBD for canine anxiety, osteoarthritis pain in dogs and cats, seizure management, and palliative care — alongside the veterinary perspectives and dosing guidance that responsible pet owners need.

Navigating the regulatory landscape for hemp-based pet products remains complex, with rules varying significantly between Australia, the United States, and Europe. Our coverage tracks APVMA guidelines, FDA enforcement actions, novel feed ingredient approvals, and the growing body of veterinary clinical evidence that is gradually legitimising cannabinoid therapy for animals. This sub-category is essential reading for veterinarians, pet product manufacturers, and animal owners exploring evidence-based alternatives.